Search research articles
Contact Us
Filters
Showing results (131-140 of 189) with videos related to
Page
of 19
Sort By:
Cancer Immunology, Immunotherapy : CII
|
October 29, 2013
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers
Mary L Disis, Yushe Dang, Andrew L Coveler, et al.
Oncotarget
|
December 16, 2016
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
Latha B Pathangey, Dustin B McCurry, Sandra J Gendler, et al.
Molecular Cancer Therapeutics
|
March 6, 2008
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity
Vivian Goodell, James Waisman, Lupe G Salazar, et al.
Vaccines
|
February 26, 2025
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer
William R Gwin, Lupe G Salazar, James Y Dai, et al.
Journal of Translational Medicine
|
September 21, 2011
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery
Davide Bedognetti, James M Balwit, Ena Wang, et al.
Journal of Translational Medicine
|
June 3, 2014
Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer
Jianning Mao, Jon Ladd, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2011
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC
Hailing Lu, Gregory N Dietsch, Maura-Ann H Matthews, et al.
Cancer Research
|
June 20, 2015
An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis
Hiroyuki Katayama, Clayton Boldt, Jon J Ladd, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells
Annemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.
Breast Cancer Research and Treatment
|
August 9, 2014
Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice
Eun-Young Gil, Uk-Hyun Jo, Hye Jin Lee, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 189) with videos related to
Sort By:
Page
of 19
Cancer Immunology, Immunotherapy : CII
|
October 29, 2013
HER-2/neu vaccine-primed autologous T-cell infusions for the treatment of advanced stage HER-2/neu expressing cancers
Mary L Disis, Yushe Dang, Andrew L Coveler, et al.
Oncotarget
|
December 16, 2016
Surrogate in vitro activation of innate immunity synergizes with interleukin-7 to unleash rapid antigen-driven outgrowth of CD4+ and CD8+ human peripheral blood T-cells naturally recognizing MUC1, HER2/neu and other tumor-associated antigens
Latha B Pathangey, Dustin B McCurry, Sandra J Gendler, et al.
Molecular Cancer Therapeutics
|
March 6, 2008
Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity
Vivian Goodell, James Waisman, Lupe G Salazar, et al.
Vaccines
|
February 26, 2025
A Phase II Study of Denileukin Diftitox in Patients with Advanced Treatment Refractory Breast Cancer
William R Gwin, Lupe G Salazar, James Y Dai, et al.
Journal of Translational Medicine
|
September 21, 2011
SITC/iSBTc Cancer Immunotherapy Biomarkers Resource Document: online resources and useful tools - a compass in the land of biomarker discovery
Davide Bedognetti, James M Balwit, Ena Wang, et al.
Journal of Translational Medicine
|
June 3, 2014
Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer
Jianning Mao, Jon Ladd, Ekram Gad, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2011
VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC
Hailing Lu, Gregory N Dietsch, Maura-Ann H Matthews, et al.
Cancer Research
|
June 20, 2015
An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis
Hiroyuki Katayama, Clayton Boldt, Jon J Ladd, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
March 5, 2003
Identification of tumor-specific antibodies in patients with breast cancer vaccinated with gene-modified allogeneic tumor cells
Annemieke Dols, Sybren L Meijer, Hong-Ming Hu, et al.
Breast Cancer Research and Treatment
|
August 9, 2014
Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice
Eun-Young Gil, Uk-Hyun Jo, Hye Jin Lee, et al.
Page
of 19